Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
Stock
REVB
REVB News & Events
-
Add to Watchlist
Trade REVB
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
REVB News
Revelation Biosciences Reports FY Net Loss
Feb 27 2026
seekingalpha
Revelation Biosciences Executes Third Reverse Stock Split in a Year
Jan 26 2026
stocktwits
Revelation Biosciences (REVB) Secures FDA Agreement for Gemini Drug's Clinical Trial Pathway
Jan 23 2026
NASDAQ.COM
Ericsson (ERIC) Reports Q4 Earnings Beat, Shares Surge 7.1%
Jan 23 2026
Benzinga
U.S. GDP Grows 4.4% as Trump Withdraws Tariffs on EU
Jan 23 2026
Benzinga
Revelation Biosciences (NASDAQ:REVB) Gains 25.22% After FDA Approval Pathway Agreement for Gemini Drug
Jan 23 2026
Benzinga
Revelation Biosciences (REVB) to Present Kidney Disease Treatment Data at Conference
Jan 15 2026
NASDAQ.COM
RevBio Receives FDA Approval for TETRANITE Clinical Trial
Dec 22 2025
Businesswire
Show More News
REVB Events
No data
REVB Monitor News
Revelation Biosciences Announces Reverse Stock Split and Financing Plan
Jan 30 2026
Revelation Biosciences Secures FDA Agreement for Gemini Drug
Jan 26 2026
Revelation Biosciences Secures FDA Agreement for Gemini Drug
Jan 23 2026
Revelation Biosciences surges after crossing above key SMA
Jan 22 2026
Revelation Biosciences to Present Kidney Disease Treatment Data
Jan 21 2026
REVB Earnings Analysis
No Data
People Also Watch
